>>Signaling Pathways>> Chromatin/Epigenetics>> DNA/RNA Methylation>>2',2'-Difluoro-2'-deoxyuridine

2',2'-Difluoro-2'-deoxyuridine (Synonyms: dFdU)

Catalog No.GC46508

An active metabolite of gemcitabine

Products are for research use only. Not for human use. We do not sell to patients.

2',2'-Difluoro-2'-deoxyuridine Chemical Structure

Cas No.: 114248-23-6

Size 가격 재고 수량
1 mg
US$67.00
재고 있음
5 mg
US$201.00
재고 있음
10 mg
US$369.00
재고 있음
25 mg
US$752.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

2',2'-Difluoro-2'-deoxyuridine is an active metabolite of the anticancer nucleoside analog gemcitabine .1 It is formed by deamination of gemcitabine by cytidine deaminase in the liver. 2',2'-Difluoro-2'-deoxyuridine is cytotoxic to HepG2 and A549 cancer cells (IC50s = 3.13 and 3.92 µM, respectively). It enhances radiation-induced cell death of ECV304 and NCI H292 cells when used at concentrations ranging from 10 to 100 µM.2

1.Veltkamp, S.A., Pluim, D., van Eijndhoven, M.A.J., et al.New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridineMol. Cancer Ther.7(8)2415-2425(2008) 2.Pauwels, B., Korst, A.E.C., Lambrechts, H.A.J., et al.The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitroCancer Chemother. Pharmacol.58(2)219-228(2006)

리뷰

Review for 2',2'-Difluoro-2'-deoxyuridine

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2',2'-Difluoro-2'-deoxyuridine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.